Dendreon is working to expand the application of its technology to discover, develop, manufacture and Dendreon is a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.Number of Partnerships: 10
